ACW - 99.6% Failure rate on Alzheimer's trials (The Odds are NOT in your favor)
Phase II Trials = FAIL - ongoing trials are up against a 99.6% failure rate & upon next results one would not wish to be holding, no matter how much dollars they have in the kitty
Holders relying on a 'proposed' R&D Rebate, the ultimate success of ASX listed stocks receiving R&D rebates and having future success are minimal in the least.
Worth CASH Backing atm, and that stands at around a $10-11 Million MC
- Forums
- ASX - Day Trading
- Day Trading Pre-market Open – 8 May 2019
Day Trading Pre-market Open – 8 May 2019, page-27
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)